Enveric Biosciences Inc. (ENVB): Price and Financial Metrics
ENVB Price/Volume Stats
| Current price | $0.35 | 52-week high | $2.92 |
| Prev. close | $0.36 | 52-week low | $0.33 |
| Day low | $0.34 | Volume | 56,000 |
| Day high | $0.37 | Avg. volume | 1,804,981 |
| 50-day MA | $0.46 | Dividend yield | N/A |
| 200-day MA | $0.70 | Market Cap | 3.48M |
ENVB Stock Price Chart Interactive Chart >
Enveric Biosciences Inc. (ENVB) Company Bio
Enveric Biosciences Inc., formerly AMERI Holdings, Inc., is a patient-central biotechnology company. The Company is focused on enhancing lives of people affected by the side effects of cancer treatments, such as radiodermatitis and chemotherapy-induced peripheral neuropathy. The Company is engaged in leveraging its clinical developments derived from ... More
ENVB Price Returns
| 1-mo | -34.74% |
| 3-mo | -34.58% |
| 6-mo | -57.31% |
| 1-year | -75.01% |
| 3-year | -99.53% |
| 5-year | N/A |
| YTD | -73.08% |
| 2023 | -37.50% |
| 2022 | -95.53% |
| 2021 | -78.17% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...